PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer
Open Access
- 22 September 2022
- journal article
- research article
- Published by Taylor & Francis Ltd in Cancer Biology & Therapy
- Vol. 23 (1), 1-11
- https://doi.org/10.1080/15384047.2022.2125260
Abstract
The tumor recurrence and drug resistance of hepatocellular carcinoma (HCC) threatened patients a lot. The mechanism should be further explored. The information of expression status and survival were available in public databases. The Western blot and immunohistochemistry staining displayed the level of related proteins. CCK-8, colony-formation assays, transwell assay and wound healing assay were performed to illustrate the ability of tumor growth, invasion and migration. In vivo model was established to verify our cell experiments. In our study, we revealed that proteasome 26S subunit, non-ATPase 12 (PSMD12) was high expressed in HCC tissues and positive related to the survival. In vitro experiments suggested that PSMD12 knockdown attenuated tumor cell growth, invasion and migration. Moreover, PSMD12 interference blocked the activation of MEK-ERK pathway. The ERK inhibitor could alleviate the tumor-promoting effect in PSMD12-overexpression cells. In addition, kinesin family member 15 (KIF15) was also observed to be highly expressed in HCC and be harmful to the survival. The public database, the images of immunohistochemistry and the western blot illustrated that PSMD12 and KIF15 was positive correlated. KIF15 knockdown impaired tumor progression and tumor-promoting effect of PSMD12. The xenograft models supported the results of cell experiments. In conclusion, PSMD12 could activated MEK-ERK pathway via KIF15 upregulation, thereby promoting tumor progression. Graphical abstractKeywords
Funding Information
- Fundamental Research Funds for the Central Universities (2042022kf1081)
This publication has 33 references indexed in Scilit:
- Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration–associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathwaysNeurobiology of Aging, 2015
- Kinesin Family Deregulation Coordinated by Bromodomain Protein ANCCA and Histone Methyltransferase MLL for Breast Cancer Cell Growth, Survival, and Tamoxifen ResistanceMolecular Cancer Research, 2014
- Hepatocellular carcinoma: clinical frontiers and perspectivesGut, 2014
- RNAi screen identifies KIF15 as a novel regulator of integrin endocytic traffickingJournal of Cell Science, 2014
- Raf Family Kinases: Old Dogs Have Learned New TricksGenes & Cancer, 2011
- Kinesin-12, a Mitotic Microtubule-Associated Motor Protein, Impacts Axonal Growth, Navigation, and BranchingJournal of Neuroscience, 2010
- Targeting the RAF–MEK–ERK pathway in cancer therapyCancer Letters, 2009
- MAP kinase signalling pathways in cancerOncogene, 2007
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalJournal of Hepatology, 2003